/Revvity%20Inc_%20logo%20on%20phone%20and%20site%20by-%20T_Schneier%20via%20Shutterstock.jpg)
With a market cap of $11.4 billion, Revvity, Inc. (RVTY) is a global health sciences company that provides advanced instruments, reagents, software, and services supporting diagnostics, genomics, drug discovery, and life sciences research.
Shares of the Waltham, Massachusetts-based company have underperformed the broader market over the past 52 weeks. RVTY stock has declined 12.5% over this time frame, while the broader S&P 500 Index ($SPX) has gained nearly 13%. However, shares of the company have risen 3.7% on a YTD basis, outpacing SPX's marginal return.